Ionisos
Ionisos, officially known as Ionisos S.A.S., is a leading player in the field of industrial sterilisation and decontamination, headquartered in France. Established in 2001, the company has rapidly expanded its operations across Europe, with significant facilities in France, Spain, and the UK, catering to diverse industries such as healthcare, pharmaceuticals, and medical devices. Ionisos offers a range of unique services, including gamma sterilisation and ethylene oxide (EtO) sterilisation, which are pivotal in ensuring the safety and efficacy of medical products. The company is recognised for its commitment to quality and compliance with stringent regulatory standards, positioning itself as a trusted partner in the sterilisation sector. With a focus on innovation and customer satisfaction, Ionisos continues to achieve notable milestones, solidifying its reputation as a market leader in sterilisation solutions.
DitchCarbon Score
How does Ionisos's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Other Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Ionisos's score of 11 is lower than 79% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Ionisos's reported carbon emissions
In 2022, Ionisos reported significant carbon emissions, totalling approximately 792,245,000 kg CO2e from Scope 1 and about 37,729,000 kg CO2e from Scope 2. This highlights the company's substantial operational impact on greenhouse gas emissions. Ionisos has set ambitious climate commitments, aiming to reduce its Scope 1 and Scope 2 greenhouse gas emissions by 42% by 2030, using 2021 as the baseline year. This target has been validated through the Science Based Targets initiative (SBTi), ensuring alignment with the global goal of limiting temperature rise to 1.5°C. Additionally, Ionisos is committed to measuring and addressing its Scope 3 emissions, which encompass indirect emissions in its value chain. These initiatives reflect Ionisos's dedication to sustainability and its proactive approach to mitigating climate change impacts within the healthcare sector.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2022 | |
|---|---|
| Scope 1 | 792,245,000 |
| Scope 2 | 37,729,000 |
| Scope 3 | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Ionisos is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
